ORIGINAL PAPER
Second generation antihistamines: assessment of the efficacy of treatment and tolerance of some preparations of this group (preliminary studies)
1
Department of Physiology and Pathophysiology, Institute of Medical Sciences, Faculty of Medicine and Health Science,
Jan Kochanowski University, Kielce, Poland
2
Laboratory of Medical Psychology and Education, Institute of Public Health, Faculty of Medicine and Health Science,
Jan Kochanowski University, Kielce, Poland
3
Gastroenterology Department, Central Clinical Hospital of Ministry of Internal Affairs and Administration, Warsaw, Poland
Submission date: 2016-02-17
Final revision date: 2016-02-29
Acceptance date: 2016-03-01
Publication date: 2016-04-05
Medical Studies 2016;32(1):18-22
KEYWORDS
TOPICS
ABSTRACT
Introduction: Second generation antihistamines are key medicines in the treatment of allergic diseases such as allergic rhinitis and allergic conjunctivitis.
Aim of the research: To compare the effectiveness of selected antihistamines and frequency of side effects in the course of their therapy in the patient opinion.
Material and methods: The study was conducted on a group of 40 patients taking rupatadine, bilastine, levocetirizine and fexofenadine. The method of diagnostic survey was used, having the character of a preliminary examination in view of the small number of people involved in the study.
Results: Among the 40 patients, side effects of the medicines only appeared in 3 respondents, which is 1.2%.
Conclusions: The new generation antihistamines in light of our studies appear to be safe and associated with few side effects. Due to the small number of surveyed people we treat these tests as preliminary to further analysis of the effectiveness of selected antihistamines.
Aim of the research: To compare the effectiveness of selected antihistamines and frequency of side effects in the course of their therapy in the patient opinion.
Material and methods: The study was conducted on a group of 40 patients taking rupatadine, bilastine, levocetirizine and fexofenadine. The method of diagnostic survey was used, having the character of a preliminary examination in view of the small number of people involved in the study.
Results: Among the 40 patients, side effects of the medicines only appeared in 3 respondents, which is 1.2%.
Conclusions: The new generation antihistamines in light of our studies appear to be safe and associated with few side effects. Due to the small number of surveyed people we treat these tests as preliminary to further analysis of the effectiveness of selected antihistamines.
REFERENCES (21)
1.
Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr, McCormick DP. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr 2003; 143: 377-85.
2.
Kaszyński M, Krasnodębska P, Krasnodębski W, Hermanowicz-Salmon J, Domagała-Kulawik J. Ocena skuteczności terapii lekami przeciwhistaminowymi II generacji. Współcz Alergol Info 2009; 1: 9-14.
3.
Czarny-Działak M, Latała-Łoś E. Evaluation of the impact of severity of itching symptoms on the level of depression in patients with allergic contact eczema (preliminary study). Studia Medyczne 2014; 30: 106-10.
4.
Bousquet J, Khaltaev N, Alvaro A, et al. Alergiczny nieżyt nosa i jego wpływ na astmę. Alergia Astma Immunol S1/08: 57-82.
5.
Mędrala W. Badanie nadreaktywności oskrzeli. In: Podstawy alergologii. Górnicki Wydawnictwo Medyczne, Wrocław 2006; 124.
6.
Fal AM (ed.). Alergia, choroby alergiczne, astma. Vol. 2. Medycyna Praktyczna, Krakow 2011; 417-8.
7.
Bartuzi Z. Dolny odcinek układu oddechowego w alergii na pokarmy. In: Alergia na pokarmy. Bartuzi Z (ed.). Mediton Oficyna Wydawnicza, Lodz 2006; 119-20.
8.
Czarny-Działak M, Głuszek S. Czy IL-25 może stanowić wspólne ogniwo patomechanizmu łączące astmę i alergiczny nieżyt nosa? Studia Medyczne 2011; 27: 65-8.
9.
Czarny-Działak M, Głuszek S. Rola interleukiny-25 w patogenezie chorób zapalnych jelit i dróg oddechowych. Studia Medyczne 2010; 26: 29-31.
10.
Aubier M, Neukirch C, Peiffer C, Melac M. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma. Allergy 2001; 56: 35-42.
11.
Tarchalska-Kryńska B. Leki przeciwhistaminowe H1 stosowane w terapii chorób alergicznych. Nowa Medycyna 1999; 1: 14-8.
12.
Martínez-Cócera C, De Molina M, Martí-Guadańo E, Pola J, Conde J, Borja J, Pérez I, Arnaiz E, Izquierdo I; Spanish Rupatadine Rhinitis Study Group. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind paralel study. J Investig Allergol Clin Immunol 2005; 15: 22-9.
13.
Layton D, Wilton L, Boshier A, Cornelius V, Harris S, Shakir SA. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. Drug Saf 2006; 29: 897-909.
14.
Reinartz SM, Overbeek SE, Kleinjan A, van Drunen CM, Braunstahl GJ, Hoogsteden HC, Fokkens WJ. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy 2005; 60: 1301-7.
15.
Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticarial in adults and children. Clin Ther 2009; 31: 1664-87.
16.
Miyabe S, Koizuka I, Ochi K, Tanaka K, Kuroda H, Takatsu M, Kinoshita H, Sugiyama Y. Effect of fexofenadine hydrochloride on cedar pollinosis. Auris Nasus Larynx 2003; 30 Suppl.: S61-8.
17.
Kakutani C, Ogino S, Ikeda H, Enomoto T. Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis. Arerugi 2006; 55: 554-65.
18.
Baroody FM, Lim MC, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg 1996; 122: 309-16.
19.
Persi L, Demoly P, Harris AG, Tisserand B, Michel FB, Bousquet J. Comparison between nasal provocation test and skin test in patients treated with loratadine and cetirizine. J Allergy Clin Immunol 1999; 103: 591-4.
20.
Maiti R, Rahman J, Jaida J, Allala U, Palani A. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. Arch Otolaryngol Head Neck Surg 2010; 136: 796-800.
21.
Eloy P, Tobback L, Imschoot J. Rupatadine relieves allergic rhinitis: a prospective observational study. B-ENT 2015; 11: 11-18.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
